These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1471539)

  • 41. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Initial investigation of the left temporoparietal region in schizophrenia by 31P magnetic resonance spectroscopy.
    O'Callaghan E; Redmond O; Ennis R; Stack J; Kinsella A; Ennis JT; Larkin C; Waddington JL
    Biol Psychiatry; 1991 Jun; 29(11):1149-52. PubMed ID: 1873375
    [No Abstract]   [Full Text] [Related]  

  • 43. Cerebral phosphorus metabolite and transverse relaxation time abnormalities in heroin-dependent subjects at onset of methadone maintenance treatment.
    Silveri MM; Pollack MH; Diaz CI; Nassar LE; Mendelson JH; Yurgelun-Todd DA; Renshaw PF; Kaufman MJ
    Psychiatry Res; 2004 Sep; 131(3):217-26. PubMed ID: 15465291
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal asymmetry of the planum temporale in patients with schizophrenia. Three-dimensional cortical morphometry with MRI.
    Kulynych JJ; Vladar K; Fantie BD; Jones DW; Weinberger DR
    Br J Psychiatry; 1995 Jun; 166(6):742-9. PubMed ID: 7663822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain dysfunction during motor activation and corpus callosum alterations in schizophrenia measured by cerebral blood flow and magnetic resonance imaging.
    Günther W; Petsch R; Steinberg R; Moser E; Streck P; Heller H; Kurtz G; Hippius H
    Biol Psychiatry; 1991 Mar; 29(6):535-55. PubMed ID: 1905162
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationship between brain structure and function in disorders of the schizophrenic spectrum: single positron emission computerized tomography, computerized tomography and psychopathology of first episodes.
    Rubin P; Hemmingsen R; Holm S; Møller-Madsen S; Hertel C; Povlsen UJ; Karle A
    Acta Psychiatr Scand; 1994 Oct; 90(4):281-9. PubMed ID: 7831999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [31P magnetic resonance spectroscopy(MRS) study in basal ganglia of patients with Parkinson's disease].
    Kudo M; Mizuno Y; Morita H; Miyazaki M
    Nihon Rinsho; 1997 Jan; 55(1):255-61. PubMed ID: 9014460
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.
    Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY
    Gastroenterology; 1995 Mar; 108(3):776-88. PubMed ID: 7875480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduction of cerebral blood flow in chronic schizophrenia: relation to age.
    Kanoh M; Kamioka Y; Takahashi S
    Jpn J Psychiatry Neurol; 1992 Mar; 46(1):113-9. PubMed ID: 1635304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo magnetic resonance spectroscopy. Applications in psychiatry.
    Maier M
    Br J Psychiatry; 1995 Sep; 167(3):299-306. PubMed ID: 7496637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Counter clockwise scalp hair whorl in schizophrenia.
    Alexander RC; Breslin N; Molnar C; Richter J; Mukherjee S
    Biol Psychiatry; 1992 Nov; 32(9):842-5. PubMed ID: 1450299
    [No Abstract]   [Full Text] [Related]  

  • 54. Neurobiological substrate of dimensions of schizophrenic illness.
    Tandon R
    J Psychiatr Res; 1995; 29(4):255-60. PubMed ID: 8847653
    [No Abstract]   [Full Text] [Related]  

  • 55. [Neurobiology of schizophrenia].
    Henn FA
    Schweiz Arch Neurol Psychiatr (1985); 1995; 146(5):224-9. PubMed ID: 8658103
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increase of phosphodiesters during neuroleptic treatment of schizophrenics: a longitudinal 31P-magnetic resonance spectroscopic study.
    Volz HP; Rössger G; Riehemann S; Hübner G; Maurer I; Wenda B; Rzanny R; Kaiser WA; Sauer H
    Biol Psychiatry; 1999 May; 45(9):1221-5. PubMed ID: 10331116
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 31P-NMR spectroscopy of isolated perfused rat lung.
    Hayashi Y; Inubushi T; Nioka S; Forster RE
    J Appl Physiol (1985); 1993 Apr; 74(4):1549-54. PubMed ID: 8514668
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study.
    Levine J; Panchalingam K; McClure RJ; Gershon S; Pettegrew JW
    Neurochem Res; 2003 May; 28(5):687-90. PubMed ID: 12716017
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Planum temporale in schizophrenia: a magnetic resonance study.
    Rossi A; Stratta P; Mattei P; Cupillari M; Bozzao A; Gallucci M; Casacchia M
    Schizophr Res; 1992 Apr; 7(1):19-22. PubMed ID: 1591193
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral metabolism in experimental hydrocephalus: an in vivo 1H and 31P magnetic resonance spectroscopy study.
    Braun KP; van Eijsden P; Vandertop WP; de Graaf RA; Gooskens RH; Tulleken KA; Nicolay K
    J Neurosurg; 1999 Oct; 91(4):660-8. PubMed ID: 10507389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.